The research shows that dermal fillers are expected to show particularly strong potential, as consumers in Asia, like their western counterparts, move towards non-invasive anti-aging treatments that are also less costly.
Overall the market for cosmetic surgery, facial aesthetics and medical laser treatments is expected to grow at well into double percentage figures to reach an estimated $1.2bn by the year 2017.
The report highlights the fact that, despite cosmetic surgeries being elective treatments and not reimbursed for insurance purposes, interest is continuing to grow in both countries, as consumers reach out for new ways of fighting signs of aging.
Hyaluronic acid fillers hit the big time
The market for dermal fillers is in China and India will be driven by increasing interest in hyaluronic acid filler treatments, which are being carried out in a fast growing network of spas and beauty clinics, mainly concentrated in urban areas.
With growth for dermal fillers again expected to be well into double digit percentage figures each year up to 2017 in both markets, iData Research says that in China alone the number of dermal procedures being carried out each year should reach 1.7 million by 2017.
The report says that the growth in hyaluronic fillers has been driven by the fact that the treatments are now more effective and there is no need for allergy tests, which in turn has helped them to surpass the once popular collagen fillers.
Collagen injections are so yesterday!
In fact, Collagen injections are expected to be practically non-existent by 2015, mainly due to the fact that the world’s number one manufacturer of Collagen fillers, US-based Allergan, stopped production of its collagen brands in 2009.
Although Allergan remains the leading global supplier of dermal fillers and is very active in the China and India markets, domestics companies have gained strong market penetration in recent years by offering lower prices.
However, polymer and particle based fillers are expected to remain popular in both China and India during the coming years, although some of this popularity is attributed to medical treatment of chronic diseases such as AIDS.